Discover trends, market shifts, and competitive outlooks for the oncology based in-vivo cro industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Oncology Based In-Vivo CRO Market Growth Performance Trended Historically, And What Lies Ahead?

The market size of the in-vivo cro specialized in oncology has experienced significant growth in the past years. It is projected to expand from $1.39 billion in 2024 to $1.5 billion in 2025, with an 8.0% compound annual growth rate (CAGR). This growth during the historical period is due to factors such as heightened attention towards oncology treatments, the increasing prevalence of cancer, a shift towards personalized medication, the growth of the pharmaceutical industry, and the demand for therapies targeting specific conditions.

The value of the oncology-focused in-vivo CRO market is anticipated to escalate swiftly in the immediate future. Predictions suggest it will elevate to “$2.28 billion by 2029, with a compound annual growth rate (CAGR) of 10.9%. This surge in the upcoming period is speculated to be due to the advent of new market prospects, shift towards immuno-oncology treatments, increase in oncology clinical trials, precision medicine, and targeted therapies. The forecast period also anticipates significant trends such as the use of regenerative medicine and cell therapies, desire for expedited drug development, digitalization and data analytics, emphasis on tumor microenvironment, and ascend in biologics and immunotherapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10521&type=smp

What are the Fundamental Drivers and Innovations Shaping the Oncology Based In-Vivo CRO Market?

The rising incidence of cancer is anticipated to fuel the expansion of the oncology-based in-vivo CRO market. Cancer is a collection of diseases characterized by the uncontrolled division of abnormal cells that exceed their normal limits, can develop in virtually any organ or tissue, and can spread to other parts of the body via the blood and lymph systems. The treatment and diagnosis of cancer necessitate the development of novel drugs and devices, which must undergo various preclinical trials, clinical trials, and regulatory procedures before they can be introduced into the market. An oncology in-vivo-based CRO is a company that a sponsor company hires to provide research services, such as carrying out all or some of the steps involved in conducting a preclinical in-vivo study (testing on living organisms like animals, plants, or whole cells) prior to the trial of the drug or device in humans. As cancer becomes more prevalent, the demand for new treatments and therapies is also rising, stimulating the growth of the oncology-based in-vivo CRO market. For example, according to the American Cancer Society, a non-profit organization in the USA, approximately 609,000 cancer-related deaths and 1.9 million new cancer cases were reported in the country in 2022. An estimated 620,000 cancer deaths are expected, representing a slight increase in mortality rates in 2024. The increasing incidence of cancer is prompting the expansion of the oncology-based in-vitro CRO market.

How Is the Oncology Based In-Vivo CRO Market Segmented?

The oncology based in-vivo cro market covered in this report is segmented –

1) By Indication: Blood Cancer, Solid Tumors, Other Indications

2) By Model: Syngeneic Model, Xenograft, Patient Derived Xenograft (PDX), Other Models

3) By Application: Hospitals, Rehabilitation Centers

Subsegments:

1) By Blood Cancer: Leukemia, Lymphoma, Myeloma

2) By Solid Tumors: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Solid Tumors

3) By Other Indications: Neuroblastoma, Germ Cell Tumors, Sarcomas, Other Specific Indications

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10521&type=smp

Which Regions Are Driving the Next Phase of the Oncology Based In-Vivo CRO Market Growth?

North America was the largest region in the oncology-based in-vivo CRO market in 2024.North America is expected to be the fastest-growing region in the global oncology-based in-vivo CRO market report during the forecast period. The regions covered in the oncology-based in-vivo CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Oncology Based In-Vivo CRO Market?

Significant players in the in vivo CRO market for oncology are pivoting towards personalized oncology models in order to maintain a competitive edge. These models leverage patient-derived xenografts (PDXs) to develop customized treatment plans, thereby improving the significance and effectiveness of preclinical studies. As an illustration, Charles River Laboratories, a life sciences firm based in the U.S., unveiled its OncoMouse platform in 2022. This platform employs PDX technology for enhanced tumor modeling accuracy. Included in its features are high-throughput screening functions and real-time tumor growth tracking, facilitating swift evaluations of therapeutic reactions. It also offers consolidated data analytics to fine-tune treatment guidelines according to each patient’s unique profile. These progressions indicate a move towards more efficient, patient-oriented approaches in the field of cancer research.

View the full report here:

https://www.thebusinessresearchcompany.com/report/oncology-based-in-vivo-cro-global-market-report

How Is the Oncology Based In-Vivo CRO Market Defined and What Are Its Core Parameters?

An oncology-based in-vivo contract research organization (CRO) refers to a company hired by another company to perform complete or partial steps of running a preclinical in-vivo study (testing or with living organisms such as animals, plants, or whole cells), such as designing, managing, monitoring, and analyzing in-vivo preclinical results for oncology drugs or devices.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10521

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model